Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2014
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889152 Capsular polysaccharides solubilisation and combination vaccines
11/18/2014US8889147 DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/18/2014US8889134 Modulators of Candida hyphal morphogenesis and uses thereof
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/13/2014US20140335086 Modified heat shock protein-antigenic peptide complex
11/11/2014US8884019 Benzimidazole compound crystal
11/11/2014US8883748 Formulation for treating fungal infection
11/11/2014US8883715 Biocompatible polymers, process for their preparation and compositions containing them
11/06/2014US20140329896 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions
11/04/2014US8877804 Sulfur derivatives as chemokine receptor modulators
11/04/2014US8877738 Antipathogenic peptides
11/04/2014US8877726 Method and medicament for inhibiting the expression of a given gene
11/04/2014US8877718 Antiinfective and antitumoral compounds isolated from tropical lianas
11/04/2014US8877211 Bovine herpes virus vaccine with multiple mutations
11/04/2014US8877169 Method of preparing hydrogel structure
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140323693 Antibodies To Non-Functional P2X7 Receptor
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871818 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method
10/28/2014US8871799 Iminochromene anti-viral compounds
10/28/2014US8871708 Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles
10/28/2014US8871436 Immunostimulatory oligonucleotides and uses thereof
10/28/2014US8871278 Stabilized hypohalous acid solutions
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/28/2014US8871224 Botulinum toxin therapy for skin disorders
10/28/2014US8871223 HSV-1 and HSV-2 vaccines and methods of use thereof
10/28/2014US8871193 Viral vectors and their use in therapeutic methods
10/23/2014US20140314714 Immunopotentiative composition
10/21/2014US8865867 Lectins and uses thereof
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/21/2014US8865469 Methods of transforming a Listeria
10/21/2014US8865201 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders
10/21/2014US8865185 Methods of use for HSV-1 and HSV-2 vaccines
10/21/2014US8865183 Treatment of pigs with PCV2 antigent
10/21/2014US8865143 Reversely thermo-reversible hydrogel compositions
10/21/2014US8865136 Antiseptic pharmaceutical composition for oral hygiene and the treatment of oral diseases of microbial origin
10/16/2014US20140308311 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
10/16/2014US20140308269 Humanized antibodies
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859525 Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
10/14/2014US8859506 Glycopeptide phosphonate derivatives
10/14/2014US8859492 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
10/14/2014US8859240 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
10/14/2014US8859231 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
10/14/2014US8858983 Antioxidants and antimicrobial accessories including antioxidants
10/14/2014US8858982 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/14/2014US8858977 Drug delivery system
10/14/2014US8858970 High load dispersions
10/14/2014US8858946 Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies
10/14/2014US8858917 Methods for limiting spread of pulmonary infections
10/09/2014WO2014165704A1 Hepatitis c viral infection treatment using a combination of compounds
10/09/2014WO2014165677A1 Expression of hiv inhibitors by mesenchymal stem cells
10/09/2014WO2014165608A1 Antibiotic protocells and related pharmaceutical formulations and methods of treatment
10/09/2014WO2014165542A1 2',4'-fluoro nucleosides for the treatment of hcv
10/09/2014WO2014165452A1 Compositions and methods for inhibiting viral activity
10/09/2014WO2014165128A2 Hepatitis b antiviral agents
10/09/2014WO2014165090A1 Compounds for the treatment of tuberculosis
10/09/2014WO2014165075A1 Antibacterial agents
10/09/2014WO2014165057A1 Compositions and methods for treating infectious disease
10/09/2014WO2014164968A1 Novel compounds for the treatment of hepatitis c
10/09/2014WO2014164771A1 Bromodomain inhibitors
10/09/2014WO2014164667A1 Dengue and west nile virus protease inhibitors
10/09/2014WO2014164526A1 Oxamazin antibiotics
10/09/2014WO2014164467A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014164428A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014164409A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014164396A1 Ablative immunotherapy
10/09/2014WO2014163257A1 Novel infectious bursal disease (ibd) virus k7 strain and vaccine against infectious bursal disease using same
10/09/2014WO2014163101A1 Fc region variant
10/09/2014WO2014162102A1 Novel mycobacterium tuberculosis target and use thereof in the screening of anti-tuberculosis drugs
10/09/2014WO2014162031A1 Recombinant vectors based on the modified vaccinia ankara virus (mva) as preventive and therapeutic vaccines against hepatitis c
10/09/2014WO2014161516A1 Oxa- and thia-diazoles useful in the treatment of tuberculosis
10/09/2014WO2014161483A1 Broad spectrum monoclonal antibody identifying ha1 structural domain of influenza virus hemagglutinin proteins
10/09/2014WO2014161412A1 Tricyclic quinolone derivative and preparation method and use thereof
10/09/2014WO2014161090A1 Campylobacter vaccine
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302090 Novel vaccine
10/08/2014EP2786760A1 Antiviral agent
10/08/2014EP2785715A1 Substituted pyridine derivatives as fabi inhibitors
10/08/2014EP2785705A1 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
10/08/2014EP2785376A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections
10/08/2014EP2785353A1 Prophylactic compositions for management of microbial infections in patients with brain injury
10/08/2014EP2785340A1 Compositions and methods for treating hepatitis c virus
10/08/2014EP2785328A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine
10/08/2014EP2785202A1 Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infection
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853357 High purity lipopeptides
10/07/2014US8853173 Synthetic glycolipid and use thereof
10/07/2014US8852914 Flavivirus vaccines
10/07/2014US8852606 Capsular polysaccharide solubilisation and combination vaccines
10/07/2014US8852602 Immunological herpes simplex virus antigens and methods for use thereof
10/02/2014WO2014160689A1 Piperazine and homopiperazine derivatives as hiv attachment inhibitors
10/02/2014WO2014160484A1 Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
10/02/2014WO2014159993A1 Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis
10/02/2014WO2014159959A1 Inhibitors of human immunodeficiency virus replication
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 1798